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The JNK interacting protein, JSAP1, has been identified as a scaffold protein for mitogen-activated protein kinase (MAPK) signaling
pathways and as a linker protein for the cargo transport along the axons. To investigate the physiological function of JSAP1 in vivo, we
generated mice lacking JSAP1. The JSAP1 null mutation produced various developmental deficits in the brain, including an axon guidance
defect of the corpus callosum, in which phospho-FAK and phospho-JNK were distributed at reduced levels. The axon guidance defect of the
corpus callosum in the jsap1/ brain was correlated with the misplacement of glial sling cells, which reverted to their normal position after
the transgenic expression of JNK interacting protein 1(JIP1). The transgenic JIP1 partially rescued the axon guidance defect of the corpus
callosum and the anterior commissure of the jsap1/ brain. The JSAP1 null mutation impaired the normal distribution of the Ca+2
regulating protein, calretinin, but not the synaptic vesicle marker, SNAP-25, along the axons of the thalamocortical tract. These results
suggest that JSAP1 is required for the axon guidance of the telencephalic commissures and the distribution of cellular protein(s) along axons
in vivo, and that the signaling network organized commonly by JIP1 and JSAP1 regulates the axon guidance in the developing brain.
D 2004 Elsevier Inc. All rights reserved.
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Mitogen-activated protein kinase (MAPK) cascades
play a role in various biological responses, including
proliferation, differentiation, and cell death (Davis, 2000;0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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1 These authors contributed equally to this work.Schaeffer and Weber, 1999). Proper localization and
sorting of the components of MAPK cascades might be
essential for controlling the specificity and efficiency of
various MAPK signalings. Three members of the JNK
interacting protein (JIP) family, JIP1 (also called JIP-1,
IB1, or SKIP), JIP2, and JSAP1 (also called JIP3), have
been cloned, and it has been proposed that they may
confer the scaffolding function for MAPK signaling
pathways (Ito et al., 1999; Kelkar et al., 2000; Whitmarsh
et al., 1998; Yasuda et al., 1999).
JSAP1 is distinct from JIP1 in terms of its primary
structure. However, both JIP1 and JSAP1 contain various277 (2005) 184–199
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purpose of their scaffolding function. JIP1 binds JNK
pathway players, including the mixed-lineage kinases
(MLKs), DLK, MKK7, and the JNKs themselves (Kim
et al., 1999; Nihalani et al., 2001; Whitmarsh et al., 1998;
Yasuda et al., 1999). In addition, JIP1 interacts with the
Alzheimer’s amyloid precursor protein (APP) (Matsuda et
al., 2001; Scheinfeld et al., 2002), p190rhoGEF (Meyer et
al., 1999), the low density lipoprotein receptor (Gotthardt
et al., 2000), and the light chain of kinesin (Verhey et al.,
2001). On the other hand, JSAP1 interacts with JNKs,
MKK4, MKK7, MEKK1, MLK3, MEK1, and c-Raf-1,
which are the key components of JNK and ERK pathways
in mammals (Ito et al., 1999; Kelkar et al., 2000; Kuboki
et al., 2000; Verhey et al., 2001). JSAP1 also interacts with
Toll-like receptor 4 (Matsuguchi et al., 2003) and FAK
(Takino et al., 2002). Molecular genetic studies revealed
that JIP1-deficient mice are developmentally normal and
viable (Im et al., 2003; Whitmarsh et al., 2001), whereas
JSAP1 null mice exhibit severe developmental defects,
including the axon guidance deficit of telencephalic
commissures (Kelkar et al., 2003), suggesting that JIP1
and JSAP1 each have a distinct role. From the in vitro
study of mouse embryonic stem (ES) cells lacking JSAP1,
Xu et al. (2003) reported that the expression of compo-
nents of JNK cascades was altered in the JSAP1-null
embryonic stem cells. Despite such studies, it has yet to be
defined whether JIP1 and JSAP1 have any overlapping
functions in vivo.
JSAP1 was detected in the cell bodies and growth cones
of neural cells cultured in vitro (Akechi et al., 2001; Sato
et al., 2004). During embryonic development in vivo,
JSAP1 is expressed mainly in the central and peripheral
nervous systems, where it is localized to axons and cell
bodies of neurons, suggesting that JSAP1 plays a role in
axonal projections. In the adult brain, JSAP1 is localized
to cell bodies in almost all neurons (Akechi et al., 2001;
Kelkar et al., 2000). JSAP1 functions as a linker protein
for the cargo transport along the axons in model
organisms. Mutations in the jsap1 homolog in Drosophila
(sunday driver) and C. elegans (unc-16) produce mis-
localized axonal cargo (Bowman et al., 2000; Byrd et al.,
2001). These reports together with subsequent studies
suggest that the JSAP1 homolog in Drosophila and C.
elegans is essential for the transport of synaptic vesicles
and signaling molecules along axon tracts (Gunawardena
and Goldstein, 2004). However, it remains to be deter-
mined whether mammalian JSAP1 also functions as an
adaptor protein for the cargo transport or cellular proteins,
as in the case of these model organisms.
The current study was undertaken to investigate the in
vivo roles of JSAP1 and JIP1 in the developing brain
using JSAP1 knockout mice and JIP1 transgenic mice. We
demonstrated that the signaling network organized com-
monly by JIP1 and JSAP1 is required for the axon
guidance of neurons.Materials and methods
Generation of JSAP1-deficient mice
In a previous study, we used a yeast two-hybrid screen to
isolate genes for the cellular factors that regulated the JNK
pathway in the brain (Kim et al., 1999). From the screening
procedure and subsequent efforts, we obtained cDNA clones
for splicing variants of rat JSAP1. The 1.4-kb rat JSAP1
cDNA clone that carried the N-terminal region of JSAP1,
including the leucine zipper domain, was used to obtain
three genomic DNA phage clones from a mouse 129/SvJ
genomic DNA library (Stratagene, USA). These phages
were characterized and found to contain over 20 kb of the
genomic DNA sequences of the jsap1 gene (Fig. 1A). The
jsap1 genomic DNA sequences characterized were depos-
ited in the GenBank (GenBank accession no. AY099109
and AY099110). The 3.5-kb genomic DNA region, includ-
ing a part of the N-terminal region of JSAP1 and the leucine
zipper domain that corresponds to the region of JIP3a from
1267 to 1708 (GenBank accession no. AF178636), was
replaced with PGK-neo sequences. The 2-kb short-arm
(HindIII/BamH1) and 6.0-kb long-arm (XhoI/EcoRI) of the
jsap1 gene were placed at each side of PGK-neo, and TK
was inserted in front of the short-arm (pJSAP1-neo-TK)
(Fig. 1A).
The homologous recombination required to make a
replacement mutation was produced in J1 embryonic stem
(ES) cells (Lee et al., 2002). Three independent ES cell
clones containing the targeted deletion of the jsap1 gene
were used to generate 10 chimeras, which in turn were bred
to C57BL/6J mice to obtain F1 heterozygotes. Intercrossing
between the F1 heterozygotes produced F2 hybrids of
homozygous ( jsap1/), heterozygous ( jsap1+/), and
wild-type ( jsap1+/+) littermates, which were used in most
of this study unless indicated otherwise. Heterozygotes and
homozygotes carrying the 129/SvJ genetic background or
C57BL/6J background were also generated and studied.
PCR or Southern blot with probe A (Figs. 1A and B) was
used for the genotype analysis. For PCR, primer sets of 6K-
3f of 5V-CGG CCA AAC GGT CCTACC-3V(1761–1778 of
JIP3a cDNA), PGK-2r of 5V-CAG CGC GGC AGA CGT
GCG CT-3V, and 6K-2r of 5V-ATC ATT GCG CAC GTG
TTC ACG-3V (1949–1969 of JIP3a cDNA) were used.
Generation of JIP1 transgenic mice
The transgenic cassette Tg-jip1 was designed to express
the mskip-2a cDNA, which is a JIP1 isoform in mice and
was also referred to as mjip-2a in a previous study (Kim et
al., 1999), under the control of the PDGFh promoter. The
Kozak sequence (CCACC) was placed in front of the ATG
codon. The BamHI/BglII fragment of mskip-2a cDNA
(from +500 to +926 bp position of mskip-2a cDNA;
GenBank accession no. AF109769) was replaced by the
1.8-kb BamHI/BglII genomic DNA sequence that contained
Fig. 1. The generation of jsap1/ mice. (A) Targeted disruption of the
jsap1 gene. The restriction map of the 129/SvJ genomic DNA sequences
(wild type), targeting cassette (pJSAP1-neo-TK), and homologous recombi-
nant (mutant). The 3.5-kb genomic DNA region including the leucine-
zipper domain of the JSAP1 cDNA (top) was replaced with PGK-neo. The
PGK-neo and TK genes were in the reverse orientation (arrows) with
respect to the jsap1 gene. B, BamH1; E, EcoRI; H, HindIII; X, XhoI; JBD,
JNK binding domain; LZ, leucine zipper domain. (B) Genomic Southern
blot of tail DNA indicating the disruption of the jsap1 gene (top). Wild-type
and targeted jsap1 loci gave rise to, respectively, 11.5- and 8.0-kb bands on
the EcoRI-digested genomic DNA blot. PCR analysis of the genomic DNA
showing the jsap1+/+, jsap1+/, and jsap1/ animals (bottom). The sizes
of both bands were approximately 800 bp. (C) Northern blot analysis of the
JSAP1 expression. Each lane contained 30 Ag of total RNA prepared from
the E18.5 brain. Northern blot analyses for the JIP1/IB1/SKIP and JIP2
expression were also shown. (D) Body weight changes of embryos during
the development stages. There was no difference in body weight between
mice with different genotypes. The numbers of embryos examined are
indicated.
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500–604, 605–685, and 686–926 bp positions of the mskip-
2a cDNA. The poly-A tail of the XbaI/NotI fragment was
obtained from the pGK-neo-pA vector (Lee et al., 2002).
mSKIP-2a was followed by the Flag epitope. The correct
splicing to form mSKIP-2Awas confirmed by Western blots
with anti-JIP1 or anti-Flag (data not shown). The PDGF-h
gene promoter (1.55 kb) was a gift from Dr. Tucker Collins
of Harvard Medical School.The purified ~3.9 kb KpnI/NotI-digested transgenic
cassette was microinjected into the pronucleus of fertilized
eggs prepared from the C57BL/6 and DBA2 hybrids. The
injected eggs were transferred to the oviducts of pseudo-
pregnant female (ICR) mice by following a standard
method, and putative transgenic founder lines were
obtained. Genomic Southern blot and PCR methods were
used for genotyping. The blots carrying BamHI-digested
genomic DNA (15 Ag per lane) were hybridized with the
32P-labeled probe prepared from the 350-bp fragment of the
N-terminal HindIII/BamHI digest of the mskip-2a cDNA
(Fig. 8B). The PCR primers were SKIP-TG1 5V-ATA ACA
TGC GCA CCG GAG CC-3V and Flag-1r 5V-ATC GTC
ATC GTC TTT GTA GTC-3V. A total of eight germ-line
transmittable founder lines were identified as carrying the
Tg-jip1 cassette, as determined by genomic PCR and
Southern blot analysis. The #34 founder line of the Tg-
jip1 mice was chosen and backcrossed to the C57BL/6
strain for six generations to obtain heterozygote N6 mice,
which were used to cross with jsap1+/, in order to obtain
double transgenic mice.
Northern blot analysis
Northern blot analyses were carried out as described
previously (Kim et al., 1999). The probes used were the
following: the 350-bp fragment of the BamH1/HindIII
digest of the mskip-2a cDNA for JIP1, the 550-bp fragment
prepared by RT–PCR with wild-type brain total RNA and
primers 5V-GGT GTA CGA TGC AGT TAA AT-3V and 5V-
CAA CTG CAC ATC GAA GCG AT-3V for JIP2 (from
1621 to 2170 of JIP2 cDNA; GenBank accession no.
NM_021921), and the 590-bp fragment generated by RT–
PCR with primers 5V-GAG CTG GAT GTG TGT CCT-3V
and 5V-TGT TCC CTT GAT GCT CTG AT-3V for JSAP1
(1091–1680 of JIP3 cDNA; GenBank accession no.
AF178636, probe B in Fig. 1A).
Western blot analysis
The brain was quickly removed from the embryo or term
neonate and homogenized in RIPA lysis buffer (50 mM
Tris–HCl, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 0.1%
SDS, and 0.1% sodium deoxycholate) containing a cocktail
of protease inhibitors (Roche, Mannheim, Germany).
Protein samples were resolved on 10% SDS–PAGE, and
specific signals on the blots were incubated with primary
antibodies listed below and visualized using an enhanced
chemiluminescence (ECL) kit (Amersham Bioscience, UK).
Antibodies used were monoclonal anti-JNK1 (1:1000)
(Pharmingen, San Diego, CA, USA), polyclonal anti-JNK3
(1:3000) (Upstate Biotechnology, Lake Placid, USA), poly-
clonal anti-phospho-JNK (1:1000) (Biosource, CA, USA),
anti-phospho-FAK (Y397) (1:1000) (Biosource); polyclonal
anti-phospho-p38 (1:1000), (New England BioLab, MA,
USA), monoclonal anti-phospho-ser-73 c-Jun (1:1000) (New
H.-Y. Ha et al. / Developmental Biology 277 (2005) 184–199 187England BioLab); polyclonal anti-JNK-2, monoclonal anti-
phospho-JNK, polyclonal anti-p38, polyclonal anti-ERK1/2,
and polyclonal anti-c-Jun (Santa Cruz Biotech, Santa Cruz,
USA). All these antibodies were used at 1:1000 except for
anti-JNK3, which was used at 1:3000. The secondary
antibodies used were peroxidase-conjugated anti-mouse
IgG, anti-rabbit-IgG, and anti-goat-IgG (Santa Cruz), which
were used at the dilution of 1:1000.
Histological analysis and immunohistochemistry
The procedures used for the cresyl violet staining and
hematoxylin and eosin (H and E) staining of serial sets of 4-
Am paraffin-embedded sections of the brain were described
previously (Che et al., 2001). For immunohistochemistry,
the brain was sectioned at 20 Am with a cryostat or 30 Am
with a vibrating microtome. Sections were stained with
polyclonal rabbit anti-calretinin (1:3000) (Chemicon Inter-
national Inc. Temecula, USA), rat monoclonal anti-L1 CAM
(1:100) (Chemicon, CA, USA), mouse monoclonal anti-
neuronal nuclei (NeuN; 1:3000) (Chemicon), polyclonal
rabbit anti-SNAP-25 (1:7000) (Sigma, MO, USA), mouse
monoclonal anti-MUNC-18 (1:3000) (BD Biosciences, CA,
USA), polyclonal rabbit anti-GFAP (1:5000) (DAKO,
Denmark), or primary antibodies used in Western blots.
Apoptotic cell death was evaluated by the TUNEL assay
using an In situ Cell Death Detection Kit (Roche).
Secondary antibodies conjugated with biotin (Santa Cruz,
USA) or TRITC (Jackson Immunoresearch, West Baltimore
Pike, PA, USA) were used at the dilution of 1:200. After
washing in PBS. Color development was processed by
incubation the sections with biotinylated HRP (Vector
Laboratories, Burlingame, CA, USA) at 1:200 for 1 h and
treated with 0.05% 3.3V-diaminobenzidine and 0.001%
H2O2 in 0.1 M Tris, pH 7.4. As necessary, the sections
were counterstained with cresyl violet or H and E. For the
TRITC-labeled sections, the sections were immediately
mounted with fluorescent mounting medium (DAKO) and
examined under a Nikon Eclipse microscope (Nikon,
Japan).Table 1
Progenies recovered from jsap1+/ intercrosses
Age (days) JSAP1 genotype Total numbers
+/+ +/ / examined
C57BL/6 and 129 heterozygote intercross
E12.5 11 20 11 42
E14.5 13 14 9 36
E16.5 13 18 19 50
E18.5 80 130 61 271
P0 17 35 19 71
P21 27 41 0 68
BALB/c heterozygote intercross
E18.5 15 32 12 59
P21 20 31 0 51Results
The JSAP1 null mutation resulted in neonatal lethality
To investigate the role of JSAP1 in vivo, we disrupted
the jsap1 gene by the homologous recombination in ES
cells, from which JSAP1 null mice were generated.
Southern blot and PCR genotyping analyses confirmed
the designed disruption of the jsap1 gene (Figs. 1A and
B). The targeted disruption completely eliminated the
expression of the jsap1 gene. The expression level of the
other members of the JNK-interacting scaffold proteins,
JIP1 and JIP2, in the brains of jsap1/ was unchanged
(Fig. 1C).Mice carrying the genetic background of the C57Bl/6J 
129/SvJ hybrid were bred. Systematic genotype analysis
indicated that the complete disruption of the jsap1 gene
resulted in neonatal lethality. The jsap1/ fetuses from
E14.5 to P0 (term neonate) were viable, and their body size
and gross morphology were normal (Fig. 1D). At E18.5, the
ratio of the number of jsap1+/+ to jsap1+/ to jsap1/
fetuses was 1:1.6:0.8, as determined among the first 271
fetuses generated from the jsap1+/ intercrosses. The
introduction of the genetic background of the BALB/c
chromosomes did not alter the neonatal lethality of jsap1/
(Table 1).
Shortly after birth, the wild-type and heterozygous term
neonates were flushed with a pink color and breathed
strongly, whereas the jsap1/ term neonates showed
cyanosis with a gradual decrease in breathing and died
within 15–20 min of their natural birth. Initially, the jsap1/
neonates showed spontaneous active movement of their four
limbs, which was indistinguishable from that of the jsap1+/+
or jsap1+/ neonates. The jsap1/ neonates exhibited
reactive behaviors by twitching both sides of the body,
including the front and hind limbs, in response to mechanical
pinching and pulling stimuli given to the tail, limb, and trunk
of the neonates.
The failure of the axon guidance of the telencephalic
commissures in the jsap1/ brain
Kelkar et al. (2003) briefly described the developmental
deficits of the telencephalic commissures in jsap1/, but
the details of the defects remain unknown. In the current
study, we examined the developmental defects in the E18.5
brain of jsap1/ in detail. The cresyl violet staining of
serial sections of the paraffin-embedded brains indicated
that the axon tracts of the corpus callosum in jsap1/ were
developed but failed to cross the midline. In the cingulate
cortex near the midline, the axons of the corpus callosum
abnormally formed the neuroma-like structures called
Probst’s bundles (Figs. 2A, B, E, and F; see also Fig. 9H).
The anterior commissure was also defective in the jsap1/
brain. The anterior and posterior branches of the anterior
Fig. 2. The failure of the axon guidance of telencephalic commissures and other gross anatomical deficits in the E18.5 brain of jsap1/. (A–H) Cresyl violet
staining of coronal (A, B, G, H, M–P) or horizontal (C–F) sections of the E18.5 brain. The axon tracts of the corpus callosum (CC) in jsap1/ were formed,
but failed to cross the midline and instead formed Probst’s bundle-like structures (B and F). The fiber tracts of the anterior commissures are also formed but did
not cross the midline (arrows in D and H). The thalamus defects (*) were asymmetrical in 11 cases among 14 defective brains as shown in H. The anterior
regions of the hippocampus were poorly developed in the jsap1/ brain (arrowheads in E–H). A schematic diagram was presented at the top of panel A to
show the level of sections in this figure. (I–L) The ventral hippocampal commissure (arrows) was developed in both jsap1+/+ and jsap1/ (I, J). The columns
of the fornix were missing in jsap1/ (arrows in L). The brain sections were stained with anti-L1 CAM (I, J) and anti-SNAP-25 (K, L). (M–P) The optic
chiasm (OX) in jsap1/ (N) was markedly increased in size compared with that in jsap1+/+ (M). The insets in M and N show the optic nerves (2nd). The optic
nerve fibers that reached the lateral geniculate nucleus of the thalamus (arrows in O, P). The brain sections were stained with anti-phospho-JNK and
hematoxylin (M, N), and anti-SNAP-25 (O, P). 2nd, optic nerve; ac, anterior commissures; aca, anterior commissures (anterior limb); acp, anterior commissures
(posterior limb); aTN, anterior thalamic nucleus; HP, hippocampus; CC, corpus callosum; CP, caudoputamen; CxP, cortical plate; fx, fornix; MZ, molecular
zone; SP, subplate; IZ, intermediate zone; VZ, ventricular zone; DG, dentate gyrus; fi, fimbria of hippocampus; LGN, lateral geniculate nucleus; LV, lateral
ventricle; sm, stria medullaris; OX, optic chiasm; V3, third ventricle; vhc, ventral hippocampal commissures; SpB, sphenoid bone; Th, thalamus. Pb, Probst’s
bundle-like structure. Scale bars, 500 Am.
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formed the main body of the anterior commissure after
joining together. However, the united axon tracts eitheradvanced poorly or were repelled from their normal path
long before they reached the midline (Figs. 2C, D, G, and
H). The failure of the axon guidance of these telencephalic
Fig. 3. The developmental defects in the cerebral cortex of the jsap1/
brain. (A, B) Cresyl violet staining of coronal sections of the E18.5 brain. The
cortical plate of the jsap1/ was narrower than that of jsap1/. (C, D) The
prefrontal cortex of the E18.5 brain stained with anti-calretinin. Many
calretinin-positive cells in the cortical plate of the jsap1/ brain migrated in
a delayed manner (arrowheads). Note the area in the marginal zone that lacks
calretinin-positive cells (arrows) in D. CxP, cortical plate; MZ, molecular
zone; SP, subplate; IZ, intermediate zone. A and C, jsap1+/+. B and D,
jsap1/. Scale bars, 300 Am.
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neonate brains of jsap1/ examined, although some
collaterals of the corpus callosum at the very posterior level
passed the midline on the odd occasion in some mutant
brains. The adult brains of the parent lines, C57BL/6J and
129/SvJ mice, as well as the heterozygote (jsap1+/), did
not show such defective phenotypes of the telencephalic
commissures.
The developmental defects in the anterior regions of the
thalamus and hippocampus of the jsap1/ brain
The JSAP1 null mutation produced developmental
deficits in the anterior dorsal regions of the thalamus in
the E18.5 brains, which was observed in the 14 cases among
the first 35 brains of jsap1/. In the case of the jsap1/
brains showing the severe thalamic defect, most of the
anterior dorsal thalamic areas were not detected, and the
midline fusion of two hemispheres in the dorsal side
appeared to be loosely formed (Figs. 2G and H). The
thalamus defects, as well as enlarged ventricle, were found
to be asymmetrical in 11 cases among 14 defective brains.
The anterior region of the hippocampus in the brain of
jsap1/ was poorly formed compared to that in jsap1+/+,
although the CA1 to CA4 regions and the dentate gyrus in
the middle and posterior levels of the hippocampus were
clearly detected (Figs. 2E–H).
The axon guidance defects of the fornix and the optic nerve
tracts in jsap1/
The axon guidance defect of the telencephalic commis-
sures prompted us to examine other large axon tracts in the
jsap1/ brain. Anti-SNAP-25 immunostaining showed
that the main efferent fiber tract of the hippocampal
formation formed the fimbria and fornix, an arch-like
structure connecting the hippocampus with the septum,
mammillary bodies and anterior thalamus in each hemi-
sphere, in the E18.5 brain of jsap1+/+. The fimbria of the
hippocampus and the following main body of the fornix
were developed in jsap1/, although the diameter of the
tracts was abnormally increased (Figs. 2E–H). The fornix in
both the jsap1+/+ and jsap1/ brains extended their axon
fiber tracts to form the ventral hippocampal commissures
that also intercrossed the midline (Figs. 2I and J), while the
main body and the columns of the fornix, which were
heading to the mammillary body in jsap1+/+, were missing
in jsap1/ (Figs. 2K and L).
We found that the optic nerves and optic chiasm in the
E18.5 brains of jsap1+/+ were strongly labeled by anti-
phospho-JNK. The optic nerve tracts in jsap1/ developed
and formed the optic chiasm. However, the diameter of the
cross-section of the optic nerve tracts and the size of the
optic chiasm were abnormally increased (Figs. 2M and N).
Most of the optic nerve fibers in jsap1/ failed to
successfully reach to the lateral geniculate nucleus of thethalamus (Figs. 2O and P). Interestingly, the increased
diameter of axon tracts was commonly found in the optic
nerves (Figs. 2M–P) and in the axon fiber tracts of the
fimbria/fornix (Figs. 2E–K), both of which showed the
failure in the projection of their tracts completely to target
structures.
The developmental defects in the cerebral cortex of the
jsap1/ brain
The cresyl violet staining of serial sections of the E18.5
brains also indicated that there were abnormalities in the
frontal and parietal cortices of jsap1/. Compared with
those in jsap1+/+, the width of the cortical plate was
narrower, and the subplate was shifted outward accord-
ingly. However, all six layers of the cortical plate were
identifiable in the E18.5 brain of jsap1/ (Figs. 3A and
B). The band of the intermediate zone in the cortex of
jsap1/ was abnormally expanded due to packing with a
large numbers of axon fibers (Figs. 3A and B). A TUNEL
staining study with the E18.5 brains showed no evidence
of increased cell death in the cortical plate of jsap1/
(data not shown).
The calcium-binding protein, calretinin, was expressed in
the E18.5 brain of jsap1+/+. The calretinin-positive regions
included the marginal zone, the subplate, the thalamocortical
fibers, and glial sling cells located underneath the corpus
Fig. 4. The developmental defects of dendrites in the cortex and the
thalamocortical and corticofugal projections in the E18.5 brains of jsap1/.
(A–D) The thalamocortical and/or corticofugal projections stained with
anti-SNAP-25 at the marked regions (rectangles) of the insets in A and B.
The anti-SNAP-25-positive axon tracts of jsap1/ were notably thick and
appeared to be overfasciculated (A and B). The number of SNAP-25-
positive fiber bundles (arrows) at the cortic-striatal junction of the jsap1/
brain (D) was markedly reduced compared with that of the jsap1+/+ brain
(C). (E, F) The thalamocortical and/or corticofugal projections stained with
anti-calretinin. The anti-calretinin labeled the thalamocortical fiber tracts at
the corticostriatal junction of jsap1/, which showed pathfinding defects
(arrows). The level of E and F is anterior to that of C and D. (G, H)
Photomicrographs showing the anti-MAP-2-stained apical dendrites
(arrowheads) in the prefrontal cortex. The marginal zone in jsap1/ was
stained more darkly and fussily. CC, corpus callosum; CxP, cortical plate;
ec, external capsule; ic, internal capsule; IZ, intermediate zone; MZ,
molecular zone; SP, subplate; tca, thalamocortical axons; A and C; jsap1+/
+. B and D; jsap1/. Scale bars in A–F are 200 Am, and in G and H, 100
Am.
Fig. 5. The distribution of the cellular protein, calretinin, and synaptic
vesicles along axons in the jsap1/ brain. (A, B) The calretinin
immunoreactivity in the axon fibers of the thalamocortical and/or cortico-
fugal projections in the subplate of the cortical plate was distributed in a
patchy and spaced-apart manner in jsap1+/+ (arrows in A), while that in
jsap1/ was diffusely distributed and frequently irregularly clustered
(arrows and arrowheads in B). Arrows and arrowheads indicate calretinin-
labeled two-axon fibers that are closely fused in the cutting surface. The
distribution of calretinin in axons was visualized by labeling with HRP and
DAB system. (C, D) The synaptic vesicle marker, SNAP-25, in the axon
fibers of the thalamocortical and/or corticofugal projections in the
intermediate zone of the cortical plate was distributed similarly in both
jsap1+/+ (C) and jsap1/ (D). Arrowheads indicate axon fiber. The
distribution of SNAP-25 in axons was visualized by labeling with TRITC.
A and C, jsap1+/+. B and D, jsap1/. Scale bars, 50 Am.
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reports (Fonseca et al., 1995; Pratt et al., 2000; Shu and
Richards, 2001; Shu et al., 2003a; Vogt-Weisenhorn et al.,
1994). The calretinin-positive cells in the cortical plate of
jsap1/ migrated in a delayed or defective manner, which
appeared to be related to the formation of many gaps in the
marginal zone that were devoid of anti-calretinin immuno-
reactivity (Figs. 3C and D).The developmental defects of dendrites in the cortex and the
thalamocortical tracts in the E18.5 brains of jsap1/
The thalamocortical and/or corticofugal tracts in the
jsap1/ brain were passed through the intermediate
zone. Their axon fibers were more strongly labeled with
anti-SNAP-25 than those of jsap1+/+. The SNAP-25-
labeled fiber tracts were abnormally thick and over-
fasciculated compared with those of jsap1+/+ (Figs. 4A
and B). While the number of the SNAP-25-positive
thalamocortical axon bundle at the corticostriatal junc-
tion in the jsap1/ brains was reduced to approxi-
mately fewer than 50% of that of jsap1+/+ (Figs. 4C
and D), a similar reduction in the number of the
MUNC-18-labeled thalamocortical axon tracts at the
corticostriatal junction was also observed (data not
shown).
The calretinin-positive thalamocortical and/or cortico-
fugal projections of jsap1/ passed in the subplate and
external capsule of the developing cortex. The calretinin-
positive fibers in these regions were sparsely running
compared with those in the jsap1+/+ brain. In addition,
many of the calretinin-positive axon fibers of the
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jsap1/ brain did not successfully pass up or down
the corticostriatal junction, thus showing pathfinding
defects. The calretinin-labeled axons in jsap1/ were
twisted or fragmented in the cutting surfaces of sections
compared with those in jsap1+/+ (Figs. 4E and F).
The JSAP1 null mutation affected the development of
dendrites in the cerebral cortex. The immunostaining with
anti-MAP-2, a dendritic marker, showed that the apical
dendrites of pyramidal neurons in the prefrontal cortex of
the jsap1/ brains were slim and branched abnormally
compared with those in jsap1+/+, suggesting that JSAP1
plays a role in the development and/or maintenance of the
dendrites (Figs. 4G and H).Fig. 6. The distribution of phospho-FAK and phospho-JNK in the axon tracts of the
of jsap1/. (A–L) Coronal sections of the E18.5 brain stained with anti-phospho-
axon fiber tracts of the corpus callosum (arrows in A–D) and the anterior commiss
The axons of the corpus callosum in jsap1/ formed neuroma-like structures calle
anti-phospho-FAK and anti-phospho-JNK (B and D). The anterior commissures (E
blots for FAK and phospho-FAK (G), ERK1/2 and phospho-ERK (H), p38a and p
Jun and phospho-c-Jun (K) in the term neonate brain. bCQ in I is a positive control f
phospho-p38 was barely detectable in the brain (I). A, C, and E, jsap1+/+. B, D, and
limb; CC, corpus callosum; CxP, cortical plate; ic, internal capsule; IZ, intermedia
SP, subplate; VZ, ventricular zone. Scale bars, 500 Am.The distribution of the cellular protein, calretinin, and
synaptic vesicles along axons in the jsap1/ brain
The calretinin immunoreactivity in the axon fibers of the
thalamocortical and/or corticofugal projections in the sub-
plate of jsap1+/+ was distributed in a patchy and spaced-
apart manner, while that in jsap1/ was much more
diffusely distributed and frequently irregularly clustered
(Figs. 5A and B), suggesting that JSAP1 plays a role in the
distribution of this protein along axons.
The distribution of synaptic vesicles along axon tracts in
the jsap1/ brain was also examined using the synaptic
vesicle markers, SNAP-25 and MUNC-18. The immunor-
eactivities of SNAP-25 and MUNC-18 were distributedtelencephalic commissures and their surrounding regions of the E18.5 brain
FAK (A, B) and phospho-JNK (C–F). These kinases were distributed in the
ures (E and F), whose development was defective in the absence of JSAP1.
d Probst’s bundles (Pb) in the cingulate cortex which were also reactive with
and F) in jsap1/ did not cross the midline (arrows in F). (G–K) Western
hospho-p38 MAPK (I), JNK1, JNK2, JNK3, and phospho-JNK (J), and c-
or phospho-p38 prepared from Zn+2-treated cultured primary astrocytes. The
F, jsap1/. ac, anterior commissures; acp, anterior commissures, posterior
te zone; LV, lateral ventricle; MZ, molecular zone; Pb, Probst’s bundle-like;
Fig. 7. The development of the glial wedge, indusium griseum, and glial
sling in the E18.5 brain of jsap1/. (A, B) Anti-GFAP staining showing
the development of the glial wedge (arrow) and glia cells of the indusium
griseum (arrowheads) in the jsap1/ brain. (C, D) Anti-NeuN staining
showing the glial sling cells (arrows). The anti-NeuN-positive cells were
detected in the subventricular zone near the glial wedge and also aberrantly
in the septum. (E, F) Anti-GFAP staining showed that the hippocampal glia
and the fimbrial glia in jsap1/ were developed normally in number, but
their developmental state was slightly less mature and stained lightly. CC,
corpus callosum; DG, dentate gyrus; fi, fimbria; IG, indusium griseum;
GW, glial wedge; Pb, Probst’s bundle-like. A, C, and E, jsap1+/+. B, D, and
F, jsap1/. Scale bars, 200 Am.
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of jsap1+/+. The thalamocortical and/or corticofugal axons
were those of the axon tracts that were strongly stained by
anti-SNAP-25 and anti-MUNC-18. The SNAP-25 immu-
noreactivity distributed in these axon fibers in the jsap1/
brain was basically comparable to that observed in the
jsap1+/+ brain (Figs. 5C and D). A similar result was
produced in the brain sections stained with anti-MUNC-18
(data not shown). We found no obvious evidence for the
trafficked or interrupted distribution of these synaptic
vesicle markers along axons of neurons in the E18.5 brains
of jsap1/.
The distribution of phospho-FAK, -JNK, and -ERK in the
axon tracts of the telencephalic commissures
We explored whether the absence of JSAP1 had any
influence on the distribution or activation of FAK, JNK, and
ERK in the E18.5 brain. The expressions of both FAK and
phospho-FAK were similarly distributed in the soma and in
the axons of neurons in most brain areas of both jsap1+/+
and jsap1/. However, the immunoreactivity of phospho-
FAK in the axonal tracts of the corpus callosum of jsap1/
was reduced compared with that of jsap1+/+ (Figs. 6A and
B). In the E18.5 brain of both jsap1+/+ and jsap1/, JNK1
was widely expressed in the brain, including the axon tracts
of the corpus callosum and the anterior commissures. The
distribution of JNK1 in these axon fibers of jsap1/ was
similar to those of jsap1+/+ (data not shown). The phospho-
JNK immunoreactivity was broadly distributed with its
expression being concentrated in large axon tracts, including
the corpus callosum and the anterior commissures of both
jsap1+/+ and jsap1/. However, the level of phospho-JNK
in the brain of jsap1/ was reduced compared with that of
jsap1+/+ (Figs. 6C–F). Phospho-ERK was distributed in the
brain of both jsap1+/+ and jsap1/ in a manner similar to
that observed for phospho-JNK (data not shown). Western
blot analysis indicated that the level of phospho-FAK, but
not FAK, in the term neonate brains of jsap1/ was
reduced compared with that of jsap1+/+. The levels of
phospho-JNK, phospho-c-Jun, and phospho-ERK, but not
JNK1, JNK2, JNK3, c-Jun, and ERK2, in the term neonate
brains of jsap1/ were also reduced (Figs. 6G–K).
Together, these results suggest that the JSAP1 deficiency
could have an influence on the activation, but not the
distribution, of FAK, JNK, and ERK in axons of the
developing brain.
The glial wedge and indusium griseum were near normally
developed, but the glial sling was misplaced in the jsap1/
brain
The glia of the indusium griseum and glial wedge are the
midline glia that act as an intermediate guidepost during the
extension of callosal axons from one hemisphere through
the midline to the opposite hemisphere (Shu and Richards,2001). Anti-GFAP staining indicated that the glia of the
indusium griseum and glial wedge in the E18.5 brain of
jsap1/ were developed similarly to those in the jsap1+/+
brain (Figs. 7A and B). The glial sling is the third structure
that acts as a guidance substratum for the developing
callosal axons (Silver and Ogawa, 1983; Silver et al., 1982).
The glial sling is not labeled by anti-GFAP in the jsap1+/+
brain, but labeled by anti-NeuN and anti-calretinin, as
reported in a recent study which reported that the glial sling
cells are a migratory population of developing neurons (Shu
et al., 2003a). Anti-calretinin and anti-NeuN staining
indicated that the glial sling cells in the jsap1/ brain
were distributed diffusely in the subventricular zone near the
glial wedge and also aberrantly in the septum area (Figs. 7C
and D). Anti-GFAP staining indicated that the hippocampal
glia and the fimbrial glia in the jsap1/ brain were
developed in a manner similar to those in the jsap1+/+ brain
(Figs. 7E and F). The numbers of anti-GFAP-labeled cells of
glial wedge and other midline glia in the jsap1/ brain
were not obviously changed. However, the developmental
state of the anti-GFAP-positive cells in the glial wedge and
in the hippocampal glia and the fimbrial glia of the jsap1/
brain appeared to be slightly less mature compared with that
in the jsap1+/+ brain.
Fig. 8. The JIP1 transgenic cassette and the transgenic mice expressing JIP1
in the brain. (A) The transgenic cassette, Tg-jip1, consists of the PDGFh
promoter, the modified mouse JIP1 splicing variant mskip-2a cDNA (Kim
et al., 1999) and polyadenylation sequence (pA). The BamHI/BglII-cut
500–926 bp of the mskip-2a cDNA (bottom) was switched with the 1.8-kb
BamHI/BglII genomic DNA fragment containing two consecutive introns
and three flaking exons (open box). The JIP1 genomic locus is indicated
(top). X, XbaI; Xh, XhoI; N, NotI; B, BamHI; Bg, BglII. (B) Genomic
Southern blot for the line Tg-jip1 #34 (B). The presence of the transgene is
indicated (arrow). N, nontransgenic control; 34, Tg-jip1 #34 line. (C) PCR
analysis indicating the presence of the transgene (582 bp, arrow). Non-Tg,
nontransgenic control; Tg-jip1, Tg-jip1 #34 line. (D) Northern blot showed
the approximately 3.0- to 3.4-kb broad band and the approximately 3.0-kb
band, which corresponded to, respectively, the endogenous JIP1 transcripts
and the transgene-derived transcript (arrows). N, nontransgenic control. 34
and 25, Tg-jip1 line #34 or #25. (E) PCR analysis of the genotypes of the
jsap1/; Tg-jip1, jsap1+/; Tg-jip1, jsap1+/+; Tg-jip1, jsap1/, and
jsap1+/ mice, jsap1 mutant, jsap1 knockout band, jsap1 wt (jsap1 wild-
type band).
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axon guidance defect of telencephalic commissures of the
JSAP1-deficient brain
The JSAP1 deficiency produced the axon guidance
defect of the corpus callosum and the anterior commissures
at the places where the axon tracts cross the midline.
However, this developmental impairment did not extend to
the ventral hippocampal commissure that also intercon-
nected both hemispheres, raising the possibility of the
functional redundancy among JSAP1-like proteins in this
structure.
To test the possibility that JSAP1 and JIP1 have a shared
function in the brain development in vivo, we generated
transgenic mouse lines that overexpressed mSKIP-2a, a
mouse JIP1 isoform, in the brain under the control of the
brain expression promoter PDGFh (Fig. 8A). This JIP1
isoform, mSKIP-2a, contains 698 amino acids including the
SH3 homologous region and the phosphotyrosine interac-
tion domain (PID) in the C-terminus (Kim et al., 1999).
Northern blot analysis revealed that the #34 founder line
strongly expressed the transgene in the brain (Figs. 8B and
C). This #34 JIP1 transgenic line, named Tg-jip1 here, was
viable and healthy and showed no obvious developmental
deficit in the brain. The transgenic JIP1 expression of the
Tg-jip1 brain was remarkably enhanced in most regions of
the brain, including in the cerebral cortex, piriform cortex,
subventricular zone, axonal bundles in the internal capsule,
septum, and glial sling, as confirmed using anti-JIP1
immunostaining (data not shown). We genetically intro-
duced the JIP1 transgene of this line into the mice lacking
JSAP1 (Fig. 8D). The resulting jsap1/;Tg-jip1 died
immediately after birth, as in the case of jsap1/, probably
because the JIP1 transgene is not sufficiently expressed in
the developing lung under the control of the PDGFh
promoter, or because JIP1 and JSAP1 have non-overlapping
functions in the lung. An analysis of the E18.5 embryos
between the jsap1/;Tg-jip1 genotype and other genotypes
showed no significant difference in their morphology, body
weight, or brain weight. Those brains that were deficient in
the jip1 gene did not show any obvious anatomical deficit in
the developed brain (data not shown).
Cresyl violet staining of coronal sections of the E18.5
brain indicated that the axonal tracts of the corpus callosum
in the jsap1/;Tg-jip1 brains completely crossed the
midline (Figs. 9A–C). Thus, the transgenic expression of
JIP1 appeared to rescue the axon guidance defect of the
corpus callosum caused by the JSAP1 deficiency. This
rescue was observed in all of the jsap1/;Tg-jip1 brains
examined, although small Probst’s bundle-like structures
remained in all cases (Figs. 9B, C, H, and I), suggesting that
some axon fibers failed to extend over the midline in the
jsap1/;Tg-jip1 brain. In addition, the jsap1/;Tg-jip1
brain showed the anterior commissures that also completely
crossed the midline (Figs. 9D–F). However, the axonal tracts
of the anterior commissures in 7 of the 12 jsap1/;Tg-jip1brains examined came close to the midline, but then headed
in the dorsal direction instead of completely forming the
midline-cross.
Anti-NeuN and anti-calretinin stainings indicated that
the transgenic expression of JIP1 relocated many of the
misplaced glia sling to their normal position, thus
allowing them to define the contour of the sling
configuration (Figs. 10A–D), so as to serve as a guidance
substratum for the developing callosal axons, as that
which has been proposed previously (Silver and Ogawa,
1983; Silver et al., 1982). Immunohistological analysis
indicated that the transgenic JIP1 partially restored the
levels of phospho-JNK and phospho-FAK in the rescued
axon fibers of the corpus callosum in the jsap1/;Tg-
jip1 brain (Figs. 11A–D).
Fig. 9. Transgenic JIP1 partially rescued the axon guidance defects of the telencephalic commissures of the JSAP1-deficient brain. (A–F) Cresyl violet staining
of coronal sections of the E18.5 brains of jsap1+/+; Tg-jip1, jsap1/; Tg-jip1, and jsap1/; Tg-jip1. The transgenic expression of JIP1 rescued the axon
guidance defect of the corpus callosum (A–C) and the anterior commissures (D–F) caused by the JSAP1 deficiency. Note the axon fiber tracts in the jsap1/;
Tg-jip1 brains that completely crossed the midline (arrows in C and F). However, all jsap1/; Tg-jip1 brain examined showed small Probst’s bundle-like
structures (Pb). The enlarged diameter of the fimbria (arrowheads) of the hippocampus was not rescued by JIP1 (D–F). The transgenic JIP1 broadened the
reduced width of the cortical plate (* on the lines), but not the intermediate zone, of the jsap1/ brain (A–C). The transgenic expression of JIP1 itself (jsap1+/
+; Tg-jip1) did not change the development of the brain (A, D, and G). (G–I) Anti-L1 CAM immunostaining of the E18.5 brain. Anti-L1 CAM strongly labeled
the axon fiber tracts of the corpus callosum in the jsap1+/+; Tg-jip1, jsap1/, and jsap1/; Tg-jip1. The defective development of the corpus callosum of
jsap1/ was partially rescued (arrows) by the transgenic JIP1 (jsap1/; Tg-jip1). The Probst’s bundle-like structures in H and I were labeled by anti-L1
CAM. ac, anterior commissures (arrows); CC, corpus callosum; fi, fimbria of hippocampus; LV, lateral ventricle; Pb, Probst’s bundle-like; CxP, cortical plate;
LV, lateral ventricle; MZ, molecular zone; SP, subplate; IZ, intermediate zone; VZ, ventricular zone. Scale bars, 500 Am.
Fig. 10. Transgenic expression of JIP1 partially restored the development of
the glial sling and the callosal axons. (A–D) Anti-NeuN (A, B) and anti-
calretinin (C, D) staining showing the development of the glial sling cells
(arrows) underneath the developing callosal axons in the jsap1/;Tg-jip1
brain. CC, corpus callosum; Pb, Probst’s bundle like. A and C, jsap1+/+;
Tg-jip1. B and D, jsap1/; Tg-jip1. Scale bar, 200 Am.
H.-Y. Ha et al. / Developmental Biology 277 (2005) 184–199194The effects of the transgenic JIP1 on other phenotypes of the
jsap1/ brain
The transgenic expression of JIP1 broadened the reduced
width of the cortical plate of the jsap1/ brain, although it
did not reduce the expanded intermediate zone (Figs. 9B
and C). The calretinin-positive cells, which were normally
found in the marginal zone of the cortical plate in the E18.5
brain of jsap1+/+, were migrated in a delayed manner or
irregularly scattered in the cortical plate of the jsap1/;Tg-
jip1 brain (data not shown), as in the case of the jsap1/
brain (Figs. 3C and F). The transgenic expression of JIP1
did not restore the defective development of the anterior
dorsal regions of the hippocampus and thalamus caused by
the jsap1 deficiency (data not shown).
The anti-calretinin immunoreactivity in the axon tracts that
run in the subplate of the developing cortex, which was
diffusely distributed or clustered in a traffic-likemanner along
the axon fibers of the thalamocortical and/or corticofugal
projections in jsap1/ (Figs. 11E and F), was not rescued by
the transgenic expression of JIP1 (data not shown). The
SNAP-25-positive thalamocortical and/or corticofugal pro-
Fig. 11. The effects of the transgenic JIP1 on other phenotypes of the
jsap1/ brain. (A–D) Photomicrographs showing the distribution of
phospho-FAK and phospho-JNK in the axon tracts of the corpus callosum.
The transgenic expression of JIP1 partially enhanced the distribution of
phospho-FAK (A, C) and phospho-JNK (B, D) in the rescued axon tracts
(arrows in C and D) of the corpus callosum. (E, F) The anti-calretinin-
positive thalamocortical fibers of the jsap1/;Tg-jip1 brain showed the
impaired transport of calretinin along the axons. The developmental defect
caused by the JSAP1 null mutation was not affected by the transgenic
expression of JIP1. IZ, intermediate zone; SP, subplate; tca, thalamocortical
axons. A, C, and E, jsap1+/+;Tg-jip1. B, D, and F, jsap1/;Tg-jip1. Scale
bars, 200 Am.
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thick and overfasciculated in the jsap1/; Tg-jip1 brain. The
pathfinding defect of the calretinin-positive thalamocortical
fibers at the corticostriatal junction was uncorrected in the
jsap1/;Tg-jip1 brain (data not shown).Discussion
The targeted disruption of the jsap1 gene in mice made it
possible to delineate the in vivo roles of JSAP1 in the
developing brain. The distinct developmental phenotypes
displayed by the jsap1/ brain, together with the results of
in vitro studies (Ito et al., 1999; Kelkar et al., 2000; Kuboki
et al., 2000), suggest that JSAP1 regulates various cellular
processes in the developing brain in vivo, including axon
guidance of the telencephalic commissures, fornix, and optic
nerve tract; the development of the cortical plate, the
anterior dorsal regions of the thalamus, and hippocampus;
and the distribution of cellular protein(s) along axons. An
important function of JSAP1 in these processes appears to
be closely related to cell-to-cell interaction. Recently, Kelkar
et al. (2003) reported that the JSAP1 deficiency produced
developmental deficits in the morphogenesis of the tele-
ncephalon, reaching a conclusion similar to ours. Given the
known role of JSAP1 in vitro as a scaffold protein for many
signaling factors, the altered function of those signaling
pathways might underlie the developmental defects of the
jsap1/ brain. Proper subcellular localization and sortingof FAK and JNK cascade components, such as JNKs,
MKK7, and MLKs, at the right place and time might be
essential for controlling the specificity and efficiency of
specific signaling of these pathways. In view of the
developmental rescue of the axon guidance defect in the
jsap1/ brain by the transgenic expression of JIP1, it is
likely that the overlapping components of the JSAP1- and
JIP1-dependent functional networks play a role in the case
of axon guidance.
Because JSAP1 interacts with FAK and ERK (Kelkar et
al., 2000; Meyer et al., 1999; Takino et al., 2002; Yujiri et
al., 2003), it may be possible that the impaired function of
FAK and/or ERK causes the developmental defects of the
jsap1/ brain. There is a wealth of evidence to support the
involvement of FAK and/or ERK pathways in cell adhesion-
related processes. In cultured embryo fibroblasts, active
ERK is targeted to newly forming focal adhesions after
integrin engagement or activation of v-Src (Fincham et al.,
2000). FAK-p130Cas complex creates an adaptor platform
linking the extracellular matrix to scaffolding proteins by
recruiting Ras, Rac1, Pak1, MKK4, and JNK1 (Almeida et
al., 2000). Our immunohistochemical analysis indicated that
FAK was expressed in the telencephalic commissures, and
the level of phospho-FAK in these axon tracts of jsap1/
was reduced compared with that of jsap1+/+ (Figs. 6A and
B). These results suggest that the JSAP1-regulated FAK
pathway may play a role in the development, such as in the
maintenance or extension, of the telencephalic commissures.
Given that the transgenic expression of JIP1 functionally
rescued the axon guidance defect of the telencephalic
commissure of the jsap1/ brain and that FAK is not
known to interact with JIP1, it remains to be determined in
the future whether altered FAK pathway is the mechanism
that leads the axon guidance defect of the telencephalic
commissures in the jsap1/ brain or whether there is an
alternative pathway involving JIP1 in regulating this
process.
The fact that JIP1 functionally rescues the axon guidance
defect of the telencephalic commissure of the jsap1/
brain strongly suggests that JIP1 has a shared function with
JSAP1 in this developmental process. The JNK pathway
components, MLK3, MKK4/MKK7, and JNKs, are the
known cellular factors that bind both JIP1 and JSAP1,
whereas FAK, ERK, APP, p190rhoGEF, ApoER2, c-Raf-1,
and Toll-like receptor 4 are known to interact with one of
them as summarized in Table 2 and Fig. 12. Therefore,
among the known signaling molecules interacted with JIP1
and JSAP1, the JNK pathway components might be chosen
as candidate factor(s) regulating the axon guidance of the
telencephalic commissures. In support of this notion, the
axon fiber tracts of the corpus callosum and the anterior
commissures in the E18.5 brain of jsap1/ showed a high
level of phospho-JNK immunoreactivity, and the level of
phospho-JNK in the jsap1/ brain was reduced (Figs. 6C–
F and J). These results suggest that the signaling pathway
for the maintenance or further extension of the telencephalic
Table 2
The molecules that interact with JSAP1 or JIP1
Binding sites Molecules References
JSAP1
Central region 410–815 MKK7 Kelkar et al., 2000
Central region 410–815 MLK3 Kelkar et al., 2000
JBD 207-216 JNKs Ito et al., 1999;
Kelkar et al., 2000
Central region 486–744 MEKK1 Ito et al., 1999
Central region MEKK4/SEK1 Ito et al., 1999;
Matsuura et al., 2002
1054–1305 MEK 1 Kuboki et al., 2000
1054–1305 c-RAF-1 Kuboki et al., 2000
N-terminal region Kinesin1 Bowman et al., 2000;
Verhey et al., 2001
N-terminal region FAK Takino et al., 2002
744–1305 ASK1 Matsuura et al., 2002
163–221 TLR4 Matsuguchi et al., 2003
420–824 JIP2 Ito et al., 1999
JIP1
283–660 MKK7 Whitmarsh et al., 1998
283–660 MEKK3 Yasuda et al., 1999
471–660 HPK Whitmarsh et al., 1998
JBD JNKs Whitmarsh et al., 1998;
Yasuda et al., 1999
471–660 MLK3 Nihalani et al., 2001;
Whitmarsh et al., 1998
471–660 DLK Whitmarsh et al., 1998
PID APP Matsuda et al., 2001;
Scheinfeld et al., 2002
307–771 Kinesin1 Verhey et al., 2001
PID p190RhoGEF Meyer et al., 1999
PID LDL-R Gotthardt et al., 2000
PID ApoER2 Stockinger et al., 2000
287–487 AKT1 Kim et al., 2002
471–707 MKP7 Willoughby et al., 2003
Undefined PAX2 Cai et al., 2002
The molecules indicated with bold letters are known to bind both JSAP1 and
JIP1. JBD, JNK binding domain; PID, phosphotyrosine interaction domain.
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axon guidance defect of these axons has to start in
developmental stages earlier than E18.5, it remains to be
examined whether the JNK pathway controls the early
development of these axons. The crucial role of the JNK
pathway in cell adhesion and neurite outgrowth has been
documented in various model systems. JNK1 is activated
and required for neurite outgrowth of cultured neuronal cell
lines (Yu et al., 2004). The anterior commissure tract is
abruptly disrupted in the neonate brain of the JNK1
knockout mice due to the failure of the maintenance of
the microtubule stability in axons (Chang et al., 2003). In
the morphogenesis of Drosophila embryos, the JNK-
mediated signaling pathway regulates the cytoskeleton
dynamics and cell shape changes required for dorsal closure
(Parsons et al., 2000). These results are tempting us to
speculate that the defective signaling of the JNK pathway
could be a mechanism that leads to the developmental
defects of the telencephalic commissures in the jsap1/
brain. This interpretation does not necessarily exclude the
possibility of appropriate interaction between the growing
axons and surrounding environment that involves JNK and
FAK pathways in these processes, as discussed in the
following paragraphs. It will be worth to test the possibility
that the developmental defects of axons (Figs. 2 and 4) and
dendrites (Figs. 4G and H) in the brains of jsap1/ are
related to the impaired regulation of the microtubule
stability.
The axonal projection of the corpus callosum across the
midline is guided by the midline glia, the indusium griseum
and glial wedge (Shu and Richards, 2001; Shu et al., 2003b;
Silver et al., 1993), and by the glial sling (Silver and Ogawa,
1983; Silver et al., 1982). Our results show that JSAP1 is
not critical for the development of the indusium griseum and
glial wedge (Figs. 7A and B) but is essential for the
developing glial sling cells to be seated in the right place
(Figs. 7C and D). The glial sling cells, which are normally
positioned underneath the corpus callosum in the jsap1+/+
brain, were found in the subventricular region near the glial
wedge and aberrantly in the septum area in the jsap1/
brain. Accordingly, they did not form the sling configu-
ration, and this altered configuration might not be suitable
for them to assume the guidepost role for the developing
callosal axons. In the jsap1/ brain with the transgenic
expression of JIP1, many glial sling cells were restored in
the normal place, and the axon tracts of the corpus callosum
were extended, as in the case of the control brain. These
results suggest that the axon guidance of the corpus
callosum is at least in part related to the interaction between
the developing axons and the glial sling cells, as was
proposed previously (Shu and Richards, 2001; Shu et al.,
2003a; Silver and Ogawa, 1983; Silver et al., 1982).
Alternatively, however, we do not exclude the possibility
that the restoration of the callosal axons by the transgenic
JIP1 might allow the sling cells to migrate toward the
midline, as discussed in a previous study (Shu et al., 2003a).The developmental impairment of the corpus callosum
and the anterior commissures in the brain of jsap1/ is also
intriguing in that mice lacking growth cone-related genes
display similar phenotypes (Richards, 2002), and JSAP1 is
strongly expressed in growth cones (Kelkar et al., 2000).
The growth cone components, including GAP-43 (Shen et
al., 2002), MAP1B (Meixner et al., 2000), p190RhoGAP
(Brouns et al., 2000), Mena (Lanier et al., 1999), and
MARCKS (Stumpo et al., 1995), interact with the cytoske-
letal component, F-actin. Furthermore, JSAP1 forms a
complex with FAK (Takino et al., 2002), which is also a
component in growth cones (Burgaya et al., 1995). These
reports suggest that the JSAP1-controlled signal pathway(s)
in the growth cone could play a role in the axon guidance of
the telencephalic commissures. However, the axon guidance
defects caused by the JSAP1 null mutation were not
penetrated into all regions in the brain of jsap1/, raising
the possibility that the physiological roles of JSAP1 might
be replaced by JSAP1-like proteins in unaffected neurons.
We demonstrated in this study that the JSAP1 null
mutation produced an abnormality in the axonal transport of
Fig. 12. A hypothetical model for the JSAP1- and JIP1-assisted regulation of FAK and JNK pathways in the focal adhesion and growth cone. The JNK pathway
components, MLK3, MKK7, and JNKs, are the known cellular factors that bind both JIP1 and JSAP1 (left panel). In the absence of JSAP1, the functional
module of FAK and/or JNK pathways may not be optimally organized in the focal adhesion or growth cone (middle panel), which might result in the failure of
normal cell adhesion or axon guidance of the telencephalic commissures. Overexpression of JIP1 may partially restore the JNK pathway in the local
environments (right panel). Arrows symbol the levels and routes of possible activation pathways.
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cortical fibers (Figs. 5A and B). This result indicates that the
mammalian JSAP1 plays a role in the distribution of cellular
factor(s) along axons, although it remains to be determined
whether its role in the axonal transport of this protein is
direct or indirect. The defective distribution of calretinin
along the axons in the jsap1/ brain appears to phenotypi-
cally imitate, in part, the altered translocation of the axonal
transport markers in the C. elegans mutant of the unc-16
(Byrd et al., 2001) or the Drosophila mutant of the sunday
driver (Bowman et al., 2000). The mutations of the JSAP1
homolog in these model organisms result in deficits in the
transport of synaptic vesicles and signaling proteins along
axons (Bowman et al., 2000; Byrd et al., 2001; Gunawar-
dena and Goldstein, 2004). However, the results of our
study do not yet exclude the possibility that the defective
transport of calretinin is produced as a result of the axon
differentiation or axon maintenance defects. Concerning
this, it will be worth to test the possibility that JSAP1
physically interacts with calretinin as that JSAP1 interacts
with JNKs or FAK. The JSAP1 null mutation in mice did
not produce any obvious deficit in the distribution of
synaptic vesicles along axons, as determined by staining
with anti-SNAP-25 (Figs. 5C and D) and anti-MUNC-18
(data now shown). These results raise the possibility that the
compensatory mechanism that controls synaptic vesicle
transport might be present. Alternatively, it is possible that
JSAP1 is not essential for, although it could contribute to,
the transport of synaptic vesicles along axons, unlike in the
case of the model organisms. Probably, further studies,
including staining axon fibers with sensitive synaptic vesicle
markers combined with a real-time video-tracking system,
might be required to be more decisive in addressing these
questions.
The ectopic expression of JIP1 failed to rescue other
phenotypes of jsap1/, including the impaired transport of
calretinin along axons, the pathfinding defect of the
thalamocortical tracts at the corticostriatal junction, andthe defective migration of the calretinin-positive cells in the
cortical plate. One possible explanation for these incomplete
rescues might be ascribed to the use of the PDGFh
promoter, instead of the JSAP1 promoter which has not
yet been characterized, to drive the transgenic expression of
JIP1. Any insufficient or improper expression of JIP1 in the
required cell types may not be able to bring about the rescue
of the developmental phenotypes caused by the JSAP1
deficiency. Alternatively, it might be that JIP1 can only
compensate for the JSAP1 deficiency in a specific cellular
process, such as the axon guidance of the telencephalic
commissures, but not in other cases, possibly because
JSAP1 and JIP1 have distinct functional roles in nature. In
support of the latter possibility, JSAP1 differs from JIP1 in
terms of their primary sequences, and these molecules
interact with distinct sets of proteins (Table 2). The JIP1 null
mutation did not produce any obvious anatomical deficits in
the brain (Im et al., 2003), whereas the JSAP1 deficiency
produced multiple defects in brain development, as demon-
strated here, and in the lung development. The fact that the
endogenous JIP1 was not sufficient to substitute for all
aspects of the JSAP1 deficiency in the jsap1/ brain also
supports the possibility of non-overlapping distribution and
function of these proteins in the developing brain.
There is the possibility that the midline fusion defect is
produced in the jsap1/ brain, which secondarily hampers
the axonal projection to cross the midline in the case of the
corpus callosum and anterior commissures. We observed
that coronal sections of the jsap1/ brains showing severe
phenotypes, such as brain sections showing thalamus
defects, were easily split into two parts at the dorsal and/
or ventral sides in the process of histological works.
Nonetheless, the results of our study also suggest that the
impairment in the development of the corpus callosum and
the anterior commissures in the jsap1/ brain has a strong
correlation with the intrinsic problems of these axons. In
support of this speculation, the axon tracts of the corpus
callosum and the anterior commissures in the jsap1/ brain
H.-Y. Ha et al. / Developmental Biology 277 (2005) 184–199198were extended but did not advance fully close to the midline
in most cases examined (Figs. 2, 6, and 9). In addition, the
fimbria and fornix, which are efferent fiber tracts of the
hippocampus, were also developed but did not completely
advance up to their target structures (Figs. 2E–L), despite
the fact that they did not need to cross the midline. In
addition, the axon tracts of the thalamocortical and/or
corticofugal projections and the optic nerves were defective,
although they also do not need to cross the midline. The
developmental phenotypes displayed by the jsap1/ brains
are so divergent and complex, yet available information
gathered from the molecular biology is too limited to
explain the observed phenotypes. Answers to questions as to
how the absence of JSAP1 determines various phenotypes
of the jsap1/ brain and whether the observed devel-
opmental phenotypes of the jsap1/ brain are directly
produced by the absence of JSAP1 per se will require more
detailed analyses using animals with tissue-/target-specific
JSAP1 knockout or studies with additional labeling tools.Acknowledgments
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